DrugDev Founder Melissa “Liss” Easy Named by PharmaVOICE as One of the Most 100 Inspirational People in the Pharmaceutical Industry in 2015
King of Prussia, PA and London, UK (PRWEB UK) 6 August 2015 -- DrugDev founder Melissa “Liss” Easy is being honored yet again for her contributions to life sciences as PharmaVOICE has named her one of the 100 most inspirational people in the industry in the annual landmark publication. Earlier in 2015, Easy was named the Partnerships in Clinical Trials Woman of the Year, and was chosen for the Philadelphia Business Journal’s “40 Under 40” list of dynamic leaders.
Easy is listed among the Entrepreneurs in the PharmaVOICE 100 issue (read her full profile).
Taren Grom, Editor-in-Chief of PharmaVOICE, explained, “Liss Easy exemplifies the passion our honorees bring to innovating and to motivating their peers and colleagues to address the industry’s most important challenges.”
Easy, who is originally from Australia, founded DrugDev as a collaborative solution and global network which connects clinical trial sponsors with investigators actively seeking new trial opportunities. She currently serves as President of DrugDev SiteStart, which manages the proprietary global investigator network and provides sponsors and CROs with solutions for ideal site identification and faster activation (including contracting and essential regulatory document collection).
DrugDev President and CEO Ibraheem “Ibs” Mahmood – a 2014 PharmaVOICE 100 honoree – said, “Liss being named to the PharmaVOICE 100 is among the most unsurprising things I’ve heard this year. Throughout her distinguished career she has made it her mission to connect sponsors with investigators and support them with the tools they need to run clinical trials better. Liss is a visionary entrepreneur, a wonderful mother and a dear friend. She is also a role model for all of us at DrugDev. Speaking for our entire company, I would like to extend a sincere congratulations – and thank you – to Liss for her years of leadership and inspiration.”
“It’s an amazing honor to be recognized among this illustrious group of people,” said Easy. “I feel it’s important to share this recognition with my colleagues at DrugDev and with our customers who share my commitment to fundamentally disrupting the way we do clinical trials so we can improve healthcare for all of us.”
About DrugDev
DrugDev is an innovative technology company which provides cloud-based solutions to help sponsors, CROs and investigators do more clinical trials together. Built around the largest global network of active opted-in investigators, DrugDev’s unified solutions suite optimizes site selection and startup, investigator payments and clinical operations. DrugDev also serves as the trusted third-party host of the revolutionary Investigator Databank collaboration and powers the TransCelerate Investigator Registry. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs rely on DrugDev technology to do more trials at drugdev.com. Connect with DrugDev on LinkedIn and Twitter.
Brenda Nashawaty, DrugDev, http://www.drugdev.com, +1 617.688.3253, [email protected]
Share this article